Skip to content

Upper Limb Spinal Cord Stimulation for Rehabilitation Enhancement

Upper Limb Spinal Cord Stimulation for Rehabilitation Enhancement

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05991804
Acronym
Up-Stim
Enrollment
18
Registered
2023-08-15
Start date
2023-06-28
Completion date
2028-04-16
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

Rehabilitation, Transcutaneous spinal cord stimulation, Upper limb

Brief summary

In the United Kingdom, there are more than 1000 new cases of spinal cord injury (SCI) each year, with around half of these injuries affecting the cervical spine. People who have reduced function and control affecting their upper limbs may have difficulty carrying out activities of daily living (ADLs), significantly affecting their independence. Recovering even partial upper limb function is a top priority among tetraplegics. Regaining voluntary function in the upper limb can have a huge impact on quality of life. Using TSCS in the upper limb for acute SCI can benefit patients early in their rehabilitation, and may reduce the number of patients with problematic spasticity at discharge. Transcutaneous spinal cord stimulation (TSCS) may provide a low-cost method of improving function and spasticity in this cohort. The aim of this feasibility study is to assess and compare the impact of adding TSCS to the standard rehabilitation of inpatients with acute SCI, compared to a sham (placebo) TSCS intervention added to standard rehabilitation, in an effort to enhance upper limb control and function.

Detailed description

Recruitment: Participants will be recruited from the Royal National Orthopaedic Hospital. A member of our research team will contact participants after they have received this information sheet to discuss participation in the study and answer any questions. People who would like to take part in the study will be asked to attend an initial session to see if they are able to tolerate non-invasive SCS. Intervention: Eligible participants will then be randomised either into the intervention group, where they will receive TSCS or sham TSCS in addition to their regular inpatient rehabilitation. We are using this trial design to assess whether adding TSCS to regular inpatient rehabilitation enhances recovery and voluntary function in this participant cohort, and to test that there is not a placebo effect. For both the sham and intervention groups, we will carry out regular assessments. Some of these assessments will be part of standard care as an inpatient at the RNOH, and others will be additional. Please see the outcome measures for further information about these assessments. Follow-up: When participants have finished their inpatient rehabilitation at the RNOH, we will carry out a semi-structured interview, where we will ask about participants' experience on this study. Interviews may take place in person, over the phone, or over video call (e.g. Microsoft Teams or Zoom). Participants will then be invited to two Follow-up Assessments at the RNOH, where all outcome measures will be repeated. Follow-up 1 will be done once the participant is 6-months post-injury, and Follow-up 2 will be done at 1-year post-injury. If the participant is already 6-months post-injury at discharge, then Follow-up 1 will occur at 1-month post-discharge.

Interventions

OTHERTranscutaneous spinal cord stimulation added to inpatient rehabilitation

Non-invasive electrical stimulation delivered over the spine, targetting movement of the upper limbs

OTHERSham transcutaneous spinal cord stimulation (placebo) added to inpatient rehabilitation

Sham transcutaneous spinal cord stimulation (placebo) added to Standard inpatient rehabilitation given at the Royal National Orthopaedic Hospital NHS Trust

Sponsors

Royal National Orthopaedic Hospital NHS Trust
CollaboratorOTHER
University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Over the age of 18 2. Recent spinal cord injury (inpatient at the RNOH) 3. Spinal cord injury level C1-C8 4. AIS A-D 5. Willing and able to provide informed consent

Exclusion criteria

1. Women who are pregnant, planning pregnancy or breastfeeding 2. Those who have a cardiac pacemaker 3. Active device at stimulating electrode site 4. Any other musculoskeletal diagnosis affecting the upper limbs 5. Spinal malignancy 6. Spinal cord injury due to cancerous growth 7. Auto-immune disorder 8. Ongoing infection 9. Uncontrolled autonomic dysreflexia 10. Complex regional pain syndrome 11. Neurological degenerative diseases 12. Peripheral nerve damage affecting the upper limbs 13. Taking part in a conflicting research study 14. People who are unable to tolerate TSCS during their first session

Design outcomes

Primary

MeasureTime frameDescription
Change in International Standards of Neurological Classification for SCI (ISNC-SCI).30 minutesThis is a is a clinician-administered scale used to classify the severity (completeness) of injury in individuals with SCI.

Secondary

MeasureTime frameDescription
Range of Motion (ROM)20 minutesThis is a is a clinician-administered scale used to classify the angles that can be achieved at each joint of the arm
Electromyography (EMG) assessments90 minutesThis will be assessed by researchers, and classifies the amount of muscle activity occurring during movements of the arms and hands.
Individual goal planning20 minutesThis is planned between the participant and their therapist, and defines what is important to the participant to gain from their rehabilitation
Modified Ashworth Scale (MAS)20 minutesThis is a is a clinician-administered scale used to classify spasticity
Tetraplegic upper limb activity questionnaire (TUAQ)30 minutesThis is a self-assessed questionnaire which is a self-assessment of hand and arm function
International SCI data sets quality of life basic data set (SCI-QoL)15 minutesThis is a self-administered short questionnaire which assesses quality of life
Semi-structured interview60 minutesParticipants will be asked to speak freely about their experience on this project and any recommendations they have for the team for future studies
Spinal Cord Independence Measure (SCIM)30 minutesThis is a self-assessed outcome which asks the rater about 3 areas of function: self-care (feeding, grooming, bathing, and dressing), respiration and sphincter management, and mobility

Countries

United Kingdom

Contacts

Primary ContactJoseph Steel, BSc
joseph.steel@nhs.net02089095500
Backup ContactSarah Massey, PhD
sarah.massey.13@ucl.ac.uk07713582559

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026